Tayebeh Roghani | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Assist. Prof. Dr. Tayebeh Roghani | Medicine and Dentistry | Best Researcher Award

Assistant Professor of Physical Therapy from Isfahan University of Medical Sciences, Iran

Dr. Tayebeh Roghani is an accomplished Assistant Professor at the Department of Physiotherapy, Faculty of Rehabilitation Sciences, Isfahan University of Medical Sciences, Iran. With over a decade of academic, clinical, and research experience, she has made significant contributions to the field of physiotherapy, especially in the areas of musculoskeletal aging and osteoporosis. Her career has been driven by a deep commitment to improving physical health outcomes for aging populations through evidence-based physiotherapeutic interventions. She has authored numerous peer-reviewed articles, systematic reviews, and book translations. Her scholarly contributions focus primarily on hyperkyphosis, balance, gait, postural control, and back muscle function, with a particular emphasis on older women. Dr. Roghani is also actively engaged in mentoring MSc students and supervising academic research projects, further demonstrating her role in fostering the next generation of rehabilitation scientists. She has participated in local and international congresses, presented both oral and poster presentations, and has acted as a peer reviewer for prestigious scientific journals. Her academic rigor, research productivity, and teaching excellence make her a standout in her field, and she is widely respected for her methodological approach to research and dedication to the advancement of physiotherapy education and practice.

Professional Profile

Education

Dr. Roghani began her academic journey in 2003 at Isfahan University of Medical Sciences, where she earned her Bachelor of Science (B.S) in Physiotherapy in 2007. Building on her foundational knowledge, she pursued her Master of Science (M.Sc.) in Physiotherapy at Tarbiat Modares University, Tehran, from 2008 to 2011. Her graduate research deepened her understanding of therapeutic methods and patient rehabilitation. She later advanced her academic qualifications by obtaining a Ph.D. in Physiotherapy from Shahid Beheshti University of Medical Sciences, Tehran, in 2017. Her doctoral work primarily investigated osteoporosis, aging-related hyperkyphosis, and associated motor control disorders in postmenopausal women. Throughout her academic training, she participated in numerous workshops and specialized courses, including ISI paper writing, systematic reviews, SPSS data analysis, and neurorehabilitation techniques. These academic milestones have equipped her with robust research capabilities and a strong theoretical foundation. Her progressive academic path, from undergraduate to doctoral studies, highlights her sustained commitment to advancing the scientific understanding of physiotherapy and promoting improved clinical interventions. Dr. Roghani’s education is not only comprehensive but also strategically aligned with her research interests and teaching roles, making her an influential academic figure in the rehabilitation sciences.

Professional Experience

Dr. Tayebeh Roghani has cultivated a distinguished professional career as a physiotherapist, academic, and researcher. Currently an Assistant Professor at Isfahan University of Medical Sciences (IUMS), she has played a key role in both clinical education and research supervision. Since 2014, she has taught numerous undergraduate and postgraduate courses, including hospital internships, therapeutic exercise, evidence-based physiotherapy, and electromyography. Her academic appointments span both Shahid Beheshti University of Medical Sciences and IUMS, reflecting her versatility and recognition across major institutions. Beyond teaching, she serves as an examiner for MSc proposals and theses, evaluating research on osteoarthritis, chronic pain, stroke rehabilitation, and more. Dr. Roghani has also contributed extensively to university-approved research projects focusing on back muscle function, hyperkyphosis, and menopause-related musculoskeletal changes. Her active role in departmental planning, curriculum development, and grand rounds further solidifies her academic leadership. Notably, she has reviewed scientific articles for reputed journals such as PLOS One and Osteoporosis International. Her professional trajectory reflects a blend of academic excellence, clinical insight, and research-driven innovation, positioning her as a leader in advancing rehabilitation practices and physiotherapy education in Iran and beyond.

Research Interest

Dr. Roghani’s primary research interests lie at the intersection of aging, musculoskeletal health, and physiotherapeutic intervention. Her research is focused on age-related hyperkyphosis, osteoporosis, motor control, and the physical functioning of older adults. She is particularly interested in understanding how spinal deformities and muscle imbalances influence postural stability, gait, and balance. Her work has extended into randomized controlled exercise trials to evaluate the effectiveness of aerobic and resistance training—both with and without external loading—on improving bone metabolism and physical fitness in postmenopausal women. Another significant area of her research is the assessment and enhancement of back extensor muscle function in individuals with age-related spinal curvature. She also investigates the clinical implications of musculoskeletal variables on abdominal bloating and gait speed in women experiencing menopause. Her approach is both experimental and evidence-based, often involving cross-sectional and comparative designs as well as systematic reviews and meta-analyses. Collaborating with both national and international researchers, she aims to translate clinical observations into scientifically validated treatment approaches. Her research not only adds depth to physiotherapy literature but also contributes to the development of effective, non-invasive interventions for aging populations.

Research Skills

Dr. Tayebeh Roghani brings a diverse set of research skills to the field of physiotherapy and rehabilitation sciences. Her proficiency includes designing and conducting randomized controlled trials, performing systematic reviews, and carrying out meta-analyses. She is well-versed in using statistical software such as SPSS for quantitative data analysis and has experience with MATLAB for modeling and simulation. Dr. Roghani is skilled in both clinical and experimental research methodologies, including biomechanical assessments, electromyography, and gait analysis. She has developed validated instruments to assess static back extensor strength and spinal curvature, enhancing reliability in clinical trials involving older women. Her understanding of hormonal biomarkers and their relationship to physical function adds a multidisciplinary edge to her research. She has also been trained in ethical research practices, data interpretation, and evidence-based protocol development. As a peer reviewer for international journals, she evaluates scientific manuscripts with a keen eye for methodological rigor and clarity. Dr. Roghani’s comprehensive research toolkit enables her to carry out robust investigations that bridge the gap between theory and clinical application, ultimately contributing to improved patient outcomes in musculoskeletal and geriatric rehabilitation.

Awards and Honors

Dr. Tayebeh Roghani has been the recipient of notable academic honors that recognize her commitment to excellence in physiotherapy education and research. During her doctoral studies, she was awarded the Ph.D. Student Distinguished Achievement Award in both the 9th and 10th Shahid Motahari Educational Festivals in 2014 and 2015 respectively. These prestigious awards are given to outstanding students who demonstrate exceptional academic performance, research quality, and educational leadership. The recognition reflects her strong dedication to physiotherapy as a scientific discipline and highlights her early contributions to the field, even before completing her Ph.D. Beyond these accolades, her selection as a peer reviewer for high-impact journals such as PLOS One, Osteoporosis International, and Physiotherapy Theory and Practice indicates professional recognition of her scholarly expertise. These honors, coupled with her institutional project approvals and invited academic roles, affirm her status as a leading academic and a role model within the field of rehabilitation sciences. Dr. Roghani’s career trajectory is marked not just by her achievements but by the consistent recognition of her excellence by peers, mentors, and academic institutions alike.

Conclusion

Dr. Tayebeh Roghani stands out as a dedicated and accomplished scholar whose contributions to the field of physiotherapy have had meaningful impact both in academia and clinical practice. With a strong educational foundation, impressive publication record, and a clear focus on aging-related musculoskeletal conditions, she brings depth, precision, and relevance to her research. Her ability to bridge theoretical knowledge with practical application positions her as a valuable asset in developing innovative rehabilitative approaches. Moreover, her role as a teacher, mentor, and examiner demonstrates her commitment to fostering the next generation of healthcare professionals. She is actively involved in collaborative research and maintains strong ties with institutional and international peers. While she has already achieved much, there remains significant potential for future growth through expanded global collaborations, grant acquisition, and continued interdisciplinary exploration. In summary, Dr. Roghani exemplifies the attributes of an outstanding researcher—rigorous, ethical, collaborative, and visionary. Her sustained efforts make her a highly suitable candidate for the Best Researcher Award, and her ongoing work promises continued advancements in rehabilitation science and physiotherapy for aging populations.

Publications Top Notes

  1. Comparison of Back Extensor Muscle Function in Older Males With and Without Age-Related Hyperkyphosis: A Protocol Study
    Journal: The Scientific Journal of Rehabilitation Medicine, 2025
    Authors: Anahita Vahdati, Hoda Niknam, Tayebeh Roghani

  2. Spinal‐Related Musculoskeletal Determinants of Functional Abdominal Bloating and Distension: A Narrative Review
    Journal: Health Science Reports, 2025
    DOI: 10.1002/hsr2.70976
    Authors: Rezvan Ghomash Baf Zadeh, Tayebeh Roghani, Amy Gladin, Wendy B. Katzman, Fateme Bokaee, Peyman Adibi

  3. Associations Between Menopause Status, Spinal-Related Musculoskeletal Variables and Gait Speed in Middle-Aged Females: A Short Report
    Journal: Musculoskeletal Care, 2024
    Authors: Faezeh Fatehi, Tayebeh Roghani, Azam Zafarbakhsh, Amy Gladin, Fateme Bokaee, Najimeh Tarkesh Isfahani, Ibrahim Abdollahpour, Hoda Niknam, Motahar Heidari-Beni, Wendy B. Katzman

  4. Comparison of Postural Balance, Muscle Force and Spinal Posture in Obese Children and Adolescents – A Protocol Study
    Journal: Iranian Journal of Diabetes and Obesity, 2024
    Authors: Fateme Reysy, Fateme Bokaee, Tayebeh Roghani, Grace O’Malley, Najimeh Tarkesh Esfahani, Motahar Heidari Beni, Roya Kelishadi

  5. Investigating the Difference Between Thoracic Kyphosis and Its Mobility in Community-Dwelling Older Men and Women
    Journal: Journal of Modern Rehabilitation, 2024
    Authors: Somayeh Mahmoodiaghdam, Maryam Nodehi, Himan Aryanfar, Tayebeh Roghani, Alireza Akbarzadeh Baghban, Minoo Khalkhali Zavieh

  6. Short and Medium-Term Effects of Kinesio Taping on Proprioception After Anterior Cruciate Ligament Reconstruction
    Journal: The Scientific Journal of Rehabilitation Medicine, 2024
    Authors: Tayebeh Roghani, Hoda Niknam, Mehdi Rezaei, Narges Jahantigh Akbari, Ali Asghar Jame Bozorgi

  7. The Association Between Physical Function and Hyperkyphosis in Older Females: A Systematic Review and Meta-Analysis
    Journal: Journal of Geriatric Physical Therapy, 2024
    Authors: Tayebeh Roghani, Diane D. Allen, Amy Gladin, Alireza Rahimi, Marziyeh Mehrabi, Zahra Sadat Rezaeian, Ziba Farajzadegan, Wendy B. Katzman

  8. The Comparison of Musculoskeletal Variables in Females With and Without Functional Abdominal Bloating: A Protocol Study
    Journal: Journal of Rehabilitation Sciences and Research, 2024
    Authors: Rezvan Ghomash Baf Zadeh, Tayebeh Roghani, Mostafa Raisi, Ibrahim Abdollahpour, Fateme Bokaee, Najimeh Tarkesh Isfahani, Seyed Mohsen Mirbod, Motahar Heidari-Beni, Peyman Adibi

Juncheng Zhang | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Mr. Juncheng Zhang | Medicine and Dentistry | Best Researcher Award

Doctor from Gansu Maternal and Child Health Care Hospital (Gansu Provincial Central Hospital), China

Dr. Juncheng Zhang is a highly experienced gynecologist with over 12 years of dedicated service in the field of obstetrics and gynecology. Currently serving as a Gynaecologist-in-charge, he has built a clinical and research career centered around women’s reproductive health, with a strong focus on cancer immunotherapy. His primary academic interest lies in the development of innovative immunotherapeutic treatments for cervical cancer, particularly adoptive cell therapy. Dr. Zhang has recently contributed to scholarly literature through a publication in the International Journal of Gynaecology & Obstetrics, underscoring his commitment to research-driven clinical advancements. Although his citation index and collaborations are still in development, his work presents significant potential for future impact in both academic and clinical communities. Dr. Zhang is recognized for his analytical thinking, patient-centered care, and efforts to bridge clinical practice with medical research. His self-motivation and commitment to continuous learning make him a valuable contributor to the medical field. With further opportunities for research collaborations and publication expansion, Dr. Zhang is on track to become a leading expert in immunotherapy for gynecological cancers. His emerging research profile demonstrates both promise and dedication to improving outcomes for patients affected by cervical cancer.

Professional Profile

Education

Dr. Juncheng Zhang’s educational foundation is rooted in medical science, with specialized training in obstetrics and gynecology. Although specific degree titles and institutions were not mentioned in his nomination form, it is clear that his qualifications have enabled him to serve as an attending physician in a clinical setting for over a decade. Typically, such a career trajectory involves earning a Bachelor of Medicine degree (MBBS or equivalent), followed by a residency or postgraduate specialization in gynecology and obstetrics. His academic background has equipped him with in-depth knowledge in both reproductive health and advanced medical interventions, particularly in the area of oncological gynecology. Dr. Zhang’s continued interest in research further reflects the academic rigor he has maintained throughout his professional development. The progression from medical training to research in immunotherapy suggests that he has received not only clinical training but also exposure to scientific research methodologies. As he continues to publish in indexed journals and engage in specialized research, it is likely that Dr. Zhang is either actively engaged in or planning to pursue further academic qualifications, such as a Master’s or Doctorate in a related field. This combination of clinical and research education forms a strong foundation for his contributions to women’s healthcare.

Professional Experience

Dr. Juncheng Zhang has amassed over 12 years of professional experience in the field of obstetrics and gynecology, currently holding the position of Gynaecologist-in-charge. His clinical responsibilities include managing women’s reproductive health, diagnosing and treating gynecological conditions, and performing both routine and complex procedures. Over the years, he has developed a profound understanding of the physiological and pathological aspects of gynecological diseases. In parallel to his clinical practice, Dr. Zhang has cultivated a strong research interest in cervical cancer, leading him to pursue scientific investigation alongside patient care. His dual role as a physician and a researcher has enabled him to directly translate clinical observations into research questions, fostering a pragmatic and relevant approach to medical research. His professional journey is marked by a transition into cancer immunotherapy, particularly the use of adoptive cell therapies, where he seeks to explore novel treatments for one of the most challenging diseases affecting women. Despite limited experience in industry consultancy or editorial roles, Dr. Zhang’s clinical leadership and emerging research credentials establish him as a dedicated and evolving professional in the medical community. His ongoing publication activity indicates a promising future trajectory, blending clinical excellence with research innovation.

Research Interests

Dr. Zhang’s primary research interests center on cervical cancer immunotherapy, a field that integrates immunology, oncology, and clinical medicine. He is particularly focused on adoptive cell therapy, which involves enhancing the body’s immune response by administering immune cells engineered or activated outside the body. This therapeutic strategy is gaining traction in cancer treatment and holds specific promise for cervical cancer, a disease with considerable global morbidity. His work on the role of CD3 and CD28 in cervical cancer cell proliferation and their impact on peripheral blood mononuclear cell (PBMC) invasion mechanisms reflects a molecular approach to understanding and combating cancer progression. Dr. Zhang aims to contribute to the scientific community by identifying innovative therapeutic pathways that improve treatment outcomes and reduce recurrence. His research bridges the gap between laboratory science and clinical application, contributing valuable knowledge to translational medicine. The use of tumor-infiltrating lymphocytes in treatment design is an especially promising avenue, and Dr. Zhang is actively exploring how this strategy can be tailored to individual patients. His focus aligns with international efforts to enhance targeted therapy and reduce treatment resistance in gynecologic oncology, and he is committed to advancing this research area through publication and potential clinical trials.

Research Skills

Dr. Juncheng Zhang demonstrates a strong command of essential research skills critical for biomedical innovation. His ability to design, execute, and analyze experiments involving immunotherapy mechanisms positions him as a competent translational researcher. He has practical experience in evaluating the roles of immune markers such as CD3 and CD28 in tumor biology, reflecting a solid grasp of molecular biology techniques. Dr. Zhang’s recent publication in an indexed journal illustrates his proficiency in scientific writing and literature synthesis. His knowledge of adoptive cell therapies further underscores familiarity with cutting-edge cancer treatment modalities and laboratory processes involved in cell preparation, expansion, and activation. Additionally, Dr. Zhang appears adept at hypothesis generation based on clinical challenges, a vital research skill that supports the development of impactful investigations. While his exposure to citation metrics and interdisciplinary collaborations may still be developing, the depth of his subject-specific expertise provides a strong foundation for future growth. As he continues to refine his research methodology and expand his publication record, Dr. Zhang is well-positioned to make significant contributions to the field of gynecologic oncology. His integrated skill set allows him to navigate both the clinical and research environments effectively, ensuring that his scientific work remains practically relevant.

Awards and Honors

While Dr. Juncheng Zhang has not listed specific awards or honors in his nomination form, his selection for consideration in the Best Researcher Award itself reflects growing recognition of his contributions to the field of cervical cancer immunotherapy. Emerging researchers often begin their award journey through peer-reviewed publications and conference presentations, milestones Dr. Zhang has started to achieve. His first major publication in a prestigious indexed journal suggests he is gaining visibility in the academic and clinical research communities. As his research matures and gains citation traction, opportunities for awards, fellowships, and research grants will likely follow. In many cases, clinician-researchers such as Dr. Zhang are recognized for bridging the gap between practice and innovation—a commendable achievement in itself. Awards in this domain typically follow impactful clinical trials, translational research breakthroughs, or innovations in patient care. With continued publication, collaborative projects, and deeper involvement in research societies, Dr. Zhang will be well-placed to receive formal honors from medical associations, academic institutions, and healthcare innovation platforms. His trajectory indicates strong potential for future awards as he builds upon his existing foundation of scientific and clinical excellence.

Conclusion

Dr. Juncheng Zhang is a promising clinician-researcher whose dedication to improving women’s healthcare through scientific innovation is clearly evident. With over a decade of experience as a gynecologist, he brings real-world clinical insights into the research laboratory, allowing for impactful, patient-centered investigation. His focused interest in cervical cancer immunotherapy, particularly in adoptive cell therapy, reflects a cutting-edge approach that aligns with global priorities in cancer research. Though his academic portfolio is still in its early stages, his first publication marks a critical step in establishing his presence in the research community. His methodological clarity, clinical depth, and strong motivation make him an ideal candidate for advanced recognition. While areas such as citation impact, professional society involvement, and collaboration are yet to be expanded, the foundations for a successful and influential research career are firmly in place. Continued publication, increased engagement in academic circles, and involvement in translational trials could significantly elevate his profile. In conclusion, Dr. Zhang is a valuable asset to the field of gynecologic oncology, and with the right opportunities and support, he has the potential to emerge as a leading figure in cancer immunotherapy research.

Publications Top Notes

  1. 🩺 Title: A rare case of pregnancy in a type II unicornuate uterus
    Journal: Asian Journal of Surgery
    Date: May 2025
    Authors: Juncheng Zhang, Yafei Wang, Hongfang Li

  2. 🦠 Title: A rare case of squamous cell carcinoma of the ovary
    Journal: Asian Journal of Surgery
    Date: May 2025
    Authors: Juncheng Zhang, Yafei Wang, Jianping Sun, Hongfang Li

Sakarie Mustafe Hidig | Medicine and Dentistry | Excellence in Research Award

Published on by Shen Awards

Dr. Sakarie Mustafe Hidig | Medicine and Dentistry | Excellence in Research Award

Researcher from Research Center Hargeisa Group Hospital, Somalia

Dr. Sakarie Mustafe Hidig is a dedicated clinical researcher and experienced surgeon with extensive international medical training and practice. Having served in various surgical departments across China and Somalia, he has developed strong expertise in hepatobiliary, gastrointestinal, trauma, and minimally invasive surgeries. Fluent in Somali, English, Chinese, Arabic, and French, Dr. Hidig’s multilingual capabilities have supported his ability to work across cultural and institutional boundaries. He is also a published author in numerous peer-reviewed journals, covering topics such as gastrointestinal bleeding, colorectal cancer surgery, trauma-related interventions, and case reports in orthopedic and abdominal surgery. His academic background, combined with practical knowledge and research insight, enables him to contribute effectively to both clinical operations and scientific advancement. With editorial board roles and peer review certifications, he is actively involved in shaping contemporary medical literature. As a member of multiple medical associations, including the Somali Medical Association, African Medical Association, and China Medical Association, Dr. Hidig continues to impact the regional and global medical communities. His commitment to patient care, clinical research, and academic excellence highlights his suitability for prestigious recognitions such as the Best Researcher Award.

Professional Profile

Education

Dr. Sakarie Mustafe Hidig possesses a strong academic foundation in the field of medicine and surgery, with a clear focus on clinical specialization and language proficiency. He earned his Doctor of Surgery from Zhejiang University, School of Medicine, where he gained advanced knowledge in surgical techniques and clinical research methodologies. Prior to this, he obtained his Master of Surgery from Xinjiang Medical University, where he deepened his understanding of general surgery and patient care. His medical journey began with a Bachelor of Medicine, Bachelor of Surgery (MBBS) from Youjiang Medical University for Nationalities, equipping him with comprehensive skills in diagnosing and managing complex medical cases. Complementing his medical training, Dr. Hidig also holds a Diploma from Guangxi University for Nationalities, School of Languages, which reflects his commitment to cultural competence and communication, vital for working in multicultural medical settings. This well-rounded educational pathway reflects both academic excellence and an adaptive mindset, allowing him to function effectively in diverse clinical and research environments. His formal qualifications from esteemed Chinese institutions have positioned him to serve in demanding healthcare systems and contribute significantly to the fields of clinical surgery and medical science.

Professional Experience

Dr. Sakarie Mustafe Hidig has amassed a wealth of professional experience in both clinical and academic settings, working with prestigious hospitals and institutions across Asia and Africa. He has served in the Division of Hepatobiliary and Pancreatic Surgery at the Fourth Affiliated Hospital, School of Medicine, Zhejiang University, where he engaged in complex surgical procedures and clinical research. He also contributed his expertise at the Affiliated Hospital of Youjiang Medical University for Nationalities and the Emergency & Trauma Surgery Department of the First Affiliated Hospital of Xinjiang Medical University, enhancing his capabilities in emergency interventions and trauma management. Additionally, he has worked in the Gastrointestinal Surgery Department of the Affiliated Hospital of Xuzhou Medical University, as well as various roles at Hargeisa Group Hospital and Hargeisa International Hospital, where he handled general and emergency surgeries. His hands-on experience across multiple departments underscores his adaptability and comprehensive surgical proficiency. Throughout his career, Dr. Hidig has consistently demonstrated a commitment to clinical excellence, patient care, and professional development. His experience spans public and private healthcare sectors, reflecting his ability to meet high clinical standards in diverse medical systems.

Research Interests

Dr. Sakarie Mustafe Hidig’s research interests are deeply rooted in clinical surgery, trauma medicine, and gastrointestinal disorders. He has explored a wide range of topics, from emergency surgery for severe chest trauma to the application of cutting-edge procedures in minimally invasive colorectal surgeries. His research often centers on improving surgical outcomes, reducing post-operative complications, and applying innovative diagnostic tools in clinical settings. He has shown a strong interest in analyzing rare and complex medical cases, such as small bowel bleeding associated with hematologic malignancies or arterial gastrointestinal fistulas, which reflect his dedication to solving challenging clinical problems. Furthermore, he is interested in comparative pharmacological studies, such as those involving amiodarone and propafenone in arrhythmia treatment, indicating his interdisciplinary approach to research. His work in knee arthroplasty and bone tumor management shows his commitment to improving orthopedic surgical care. Overall, Dr. Hidig’s research aims to bridge clinical practice with scientific inquiry, enabling evidence-based improvements in surgical procedures and patient outcomes. His interests continue to expand as he contributes to both routine and specialized areas of medical research, with a vision for developing patient-centered, efficient, and innovative surgical interventions.

Research Skills

Dr. Hidig possesses a robust set of research skills that complement his clinical expertise. He is proficient in conducting literature reviews, designing and implementing clinical research protocols, analyzing medical data, and publishing in peer-reviewed journals. A notable strength is his capability in SPSS data analysis, which he applies in interpreting surgical outcomes and clinical trials. His experience as a peer reviewer and editorial board member has refined his understanding of research quality and scholarly communication. He also excels in case study documentation, having authored several rare case reports that have been published internationally. His skills extend to laparoscopic and minimally invasive surgical techniques, where he has not only practiced but also contributed to methodological advancements through his research. Additionally, he demonstrates competence in Microsoft Office tools, crucial for creating presentations, reports, and manuscripts. With an interdisciplinary approach, he often integrates clinical observations with evidence-based research to produce impactful findings. His multilingual ability aids in cross-border collaborations and academic exchanges. Altogether, Dr. Hidig’s research skills empower him to lead clinical studies, contribute to scholarly discourse, and innovate within the surgical field.

Awards and Honors

Dr. Sakarie Mustafe Hidig has been recognized by multiple esteemed medical and research organizations for his academic and professional contributions. He holds the distinction of being a Young Research Fellow Member of the Somali Association for Science (SAS), reflecting his early recognition as an emerging leader in clinical research. His membership ID SAS/SYRFM/088/2023 signifies his formal acknowledgment within this scholarly body. Additionally, he is a Regular Fellow Member of the International Organization for Academic and Scientific Development (IOASD), which attests to his ongoing engagement in global scientific communities. Dr. Hidig is also a respected member of the Somali Medical Association, the African Medical Association, and the China Medical Association, organizations that honor excellence in healthcare practice and research. Through these affiliations, he has participated in various conferences, professional trainings, and collaborative research initiatives. His editorial board memberships and certifications as a peer reviewer further underscore the trust placed in him by academic journals and the broader research community. These accolades and roles demonstrate his dedication to advancing the frontiers of medical science and his continued influence on international platforms of surgical and clinical research.

Conclusion

In summary, Dr. Sakarie Mustafe Hidig exemplifies the ideal candidate for recognition through the Best Researcher Award. With a solid academic foundation, diverse clinical experience, and an impressive portfolio of research contributions, he brings a multifaceted approach to modern surgical science. His career reflects a continuous commitment to improving patient outcomes, advancing surgical techniques, and promoting scholarly excellence. Fluent in five languages and skilled in both qualitative and quantitative research methods, he seamlessly integrates global perspectives into his practice and publications. Dr. Hidig’s work spans complex case reports, pharmacological studies, trauma and gastrointestinal surgery, and orthopedic procedures, demonstrating a wide scope of knowledge and versatility. His active participation in academic communities, professional societies, and editorial review boards further enhances his reputation as a leader in the field. As he continues to make meaningful contributions to healthcare and clinical research, his achievements serve as a benchmark for aspiring medical professionals. Recognizing his efforts through this award would not only honor his past accomplishments but also encourage continued innovation and collaboration in the global medical community.

Publications Top Notes

  1. Exploring the Role of m7G Modification in Cancer: Mechanisms, Regulatory Proteins, and Biomarker Potential
    Authors: Y Zhang, W Xu, C Peng, S Ren, SM Hidig, C Zhang
    Journal: Cellular Signalling, 2024, Article ID: 111288
    Citations: 10

  2. Understanding the Incidence, Screening, and Burden of Cancer in Somalia: A Literature
    Authors: SM Hidig, MM Adan
    Journal: GSJ, Vol. 12 (1), 2024
    Citations: 3

  3. An Overview of Current Pancreatic Cancer Diagnosis and Treatment in China
    Author: SM Hidig
    Journal: IOASD Journal of Medical and Pharmaceutical Sciences, Vol. 1 (1), pp. 60–67, 2024
    Citations: 2

  4. High Hepatocellular Carcinoma Rates in African Nations: Challenges and Possibilities
    Author: SM Hidig
    Journal: International Journal of Recent Research in Interdisciplinary Sciences, 2024
    Citations: 2

  5. Does Mild Flexion of the Femoral Prosthesis in Total Knee Arthroplasty Result in Better Early Postoperative Outcomes?
    Authors: H Zhou, ZR Wu, XY Chen, LS Zhang, JC Zhang, SM Hidig, S Feng, et al.
    Journal: BMC Musculoskeletal Disorders, Vol. 24 (1), Article 711, 2023
    Citations: 6

  6. Diagnostic Value of Mean Platelet Volume Combined with Thromboelastography for Coagulation State after Total Knee Arthroplasty
    Authors: JH Chen, H Zhou, Q Zhang, H Wang, SM Hidig, XY Chen, S Feng
    Journal: Clinical Hemorheology and Microcirculation, Vol. 84 (3), pp. 321–331, 2023
    Citations: 4

  7. The Challenges Facing the Healthcare System in Somalia: A Review and The Way Forward
    Authors: SM Hidig, MHA Rahman Ali, GA Egeh
    Journal: Healthcare Issues, Vol. 3 (1), pp. 6–16, 2024
    Citations: 2

  8. Assessing Healthcare Challenges in Somalia: A 2024 Perspective
    Author: SM Hidig
    Journal: ACH Medical Journal, Vol. 3 (1), pp. 346–347, 2024
    Citations: 2

  9. Traditional Education and Modern Teaching in Somaliland: A Comprehensive Review
    Authors: SM Hidig, AM Saed
    Journal: Journal of Arts Humanities and Social Sciences (GASJAHSS), 2023
    Citations: 2

  10. Promotion Policy and Employee Performance in Golls Telecommunication Company in Dhahar District, Puntland, Somalia
    Author: AM Hidig
    Institution: Kampala International University, 2014
    Citations: 2

 

 

Willi Tarver | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Dr. Willi Tarver | Medicine and Dentistry | Best Researcher Award

Assistant Professor from The Ohio State University, United States

Dr. Willi L. Tarver is a distinguished Assistant Professor in the Division of Cancer Prevention and Control at The Ohio State University, where he leverages his interdisciplinary expertise to address disparities in healthcare delivery and cancer outcomes. With a strong foundation in public health informatics, behavioral oncology, and medical library sciences, Dr. Tarver’s research focuses on integrating patient-reported outcomes (PROs), electronic tools, and equity-focused interventions to better engage underserved populations in the cancer care continuum. His professional trajectory includes advanced fellowships in behavioral oncology and medical informatics, and he is actively involved in federally funded research projects. Dr. Tarver is also deeply committed to mentoring students and early-career professionals, especially from underrepresented backgrounds. His scholarly work addresses systemic issues in healthcare access and aims to develop scalable, tech-based strategies to reduce disparities. In addition to research and teaching, he plays key roles in administrative and clinical improvement initiatives within OSU’s Quality Improvement Hub. Dr. Tarver’s growing leadership within national organizations, innovative approach to equitable cancer prevention, and consistent focus on translating research into real-world applications position him as a leader in academic medicine and public health. He is a compelling nominee for the Best Researcher Award.

Professional Profile

Education

Dr. Tarver’s educational background reflects a unique and valuable combination of public health, information science, and communication, which together form the backbone of his interdisciplinary research. He earned his Doctor of Public Health (Dr.P.H.) from the University of Alabama at Birmingham, where he was also a recipient of the prestigious NCI Diversity Supplement under the Cancer Prevention and Control Training Program. Prior to this, he completed dual Master’s degrees in Public Health (MPH) and Library and Information Science (MLIS) at the University of South Florida. His foundational undergraduate training includes a B.A. in Communication from Columbus State University and an A.S. in Pre-Pharmacy from Gordon College. Dr. Tarver further sharpened his expertise through two postdoctoral fellowships: one in Behavioral Oncology at Indiana University and another in Medical Informatics at the VA Medical Center in Indianapolis. These fellowships provided him with advanced training in clinical research, data analytics, and healthcare system improvement. His broad and deep academic background allows him to bridge clinical research, informatics, and patient-centered interventions—a combination that has enabled his innovative work in cancer disparities and technology-enhanced health solutions.

Professional Experience

Dr. Tarver’s professional journey is defined by a blend of academic, clinical, and administrative roles that support his contributions to cancer prevention, health equity, and public health informatics. Currently serving as an Assistant Professor in the Division of Cancer Prevention and Control within the Department of Internal Medicine at The Ohio State University, he has held this role since 2019. Prior to this appointment, he was a postdoctoral and informatics fellow at the Roudebush VA Medical Center and Indiana University–Purdue University Indianapolis. During his time at the VA, Dr. Tarver contributed to the Center for Health Information and Communication, refining his expertise in applying informatics to support equitable healthcare delivery. His professional roles also extend into quality improvement, where he co-led the Health Equity Core at OSU’s Quality Improvement Hub from 2022 to 2024. Dr. Tarver is an active mentor in OSU’s Center for Cancer Health Equity Summer Research Program, guiding underrepresented students in impactful, community-focused projects. In addition, he participates in institutional governance as a member of OSU’s Innovation Council. Across his roles, he has demonstrated consistent leadership, interdisciplinary collaboration, and a deep commitment to improving health outcomes through equitable and data-driven approaches.

Research Interests

Dr. Tarver’s research is driven by a deep commitment to eliminating disparities in cancer prevention and control through the integration of technology, public health, and clinical practice. His primary interest lies in the development and evaluation of patient-centered technologies—particularly electronic patient-reported outcomes (ePRO) tools—to better engage underserved populations and inform health system decision-making. His projects explore how these tools can be tailored to the unique needs of minority communities, improve cancer survivorship planning, and enhance real-time communication between patients and providers. Another major area of interest is health equity, where Dr. Tarver investigates the impact of perceived discrimination, systemic biases, and cultural barriers on cancer care utilization and outcomes. Additionally, he is involved in research that evaluates educational interventions designed to reduce STEM-related biases in high school learning environments. Through his interdisciplinary work, Dr. Tarver aims to generate actionable insights that not only contribute to academic knowledge but also guide policy reforms and clinical practices. His interests span behavioral oncology, implementation science, and medical informatics, positioning him at the forefront of translational research that impacts patient lives while advancing health equity on a systemic scale.

Research Skills

Dr. Tarver possesses a robust skill set in both qualitative and quantitative research methodologies, which he applies to projects at the intersection of health equity, informatics, and cancer prevention. He is highly experienced in designing and analyzing patient-reported outcomes (PROs), particularly within underserved and minority populations. His expertise includes conducting structured interviews, participant observation, and systematic reviews—skills he actively shares as a guest lecturer in OSU’s Public Health Informatics course. Dr. Tarver is also proficient in research related to intervention development and evaluation, including randomized trials and implementation science frameworks. His grant-writing capabilities are demonstrated by his role as Principal Investigator (PI) and Co-Investigator (Co-I) on several federal and institutional research awards. He collaborates across disciplines, including clinical medicine, education, behavioral science, and information systems, to build comprehensive research designs. Additionally, he has applied informatics tools for data visualization, regulatory decision-making, and game-based learning assessments. These skills empower him to execute complex, multilevel projects with real-world applicability and high translational value. His research toolkit is complemented by strong mentorship abilities, fostering new talent and promoting equity-focused research within academic and clinical settings.

Awards and Honors

Dr. Tarver has received multiple prestigious honors that reflect his academic excellence, research promise, and commitment to advancing health equity. He was honored with the Young Investigator Award at the VA Medical Center in Indianapolis, recognizing his early-career contributions to cancer prevention research. His selection for the VA Advanced Fellowship in Medical Informatics further highlights his potential as a leader in data-driven health solutions. As a fellow in Behavioral Oncology at Indiana University, he gained national recognition for his work integrating psychological, behavioral, and technological approaches to patient-centered care. Notably, he was a recipient of the Diversity Supplement from the National Cancer Institute (NCI) through the University of Alabama at Birmingham, affirming his focus on minority health and health disparities. Earlier in his academic journey, he was awarded the ALSTARS Scholarship at the University of South Florida for academic merit and leadership. These accolades not only reflect his dedication to research excellence but also underscore the national recognition he has received for addressing some of the most pressing challenges in health equity, cancer care, and public health education.

Conclusion

In conclusion, Dr. Willi L. Tarver stands out as an exceptionally well-rounded and impactful academic professional whose contributions significantly advance the fields of cancer prevention, public health informatics, and health equity. His ability to bridge research, mentorship, education, and clinical innovation uniquely qualifies him for the Best Researcher Award. Through interdisciplinary training, funded research projects, and active mentorship, Dr. Tarver continues to address real-world health disparities and improve patient outcomes, particularly in underserved communities. His track record as a Principal Investigator and collaborator on diverse research grants highlights his leadership and collaborative capabilities. Moreover, his mentorship of minority students and involvement in institutional quality improvement initiatives reflect a long-term investment in both people and systems. With a growing portfolio of honors, active society memberships, and educational contributions, Dr. Tarver is positioned for continued excellence and recognition in the academic and public health communities. His work exemplifies the values of translational research, social impact, and scientific integrity, making him a deserving and distinguished candidate for the Best Researcher Award.

Publications Top Notes

1. Family structure and risk behaviors: the role of the family meal in assessing likelihood of adolescent risk behaviors
📅 Year: 2014
✍️ Authors: S. Goldfarb, W.L. Tarver, B. Sen
📰 Psychology Research and Behavior Management, pp. 53–66
📈 Citations: 83

2. The use of cancer-specific patient-centered technologies among underserved populations in the United States: systematic review
📅 Year: 2019
✍️ Authors: W.L. Tarver, D.A. Haggstrom
📰 Journal of Medical Internet Research, 21(4), e10256
📈 Citations: 68

3. Growth dynamics of patient-provider internet communication: trend analysis using the Health Information National Trends Survey (2003 to 2013)
📅 Year: 2018
✍️ Authors: W.L. Tarver, T. Menser, B.W. Hesse, T.J. Johnson, E. Beckjord, E.W. Ford, et al.
📰 Journal of Medical Internet Research, 20(3), e109
📈 Citations: 56

4. A systematic review of the association between family meals and adolescent risk outcomes
📅 Year: 2015
✍️ Authors: S.S. Goldfarb, W.L. Tarver, J.L. Locher, J. Preskitt, B. Sen
📰 Journal of Adolescence, 44, pp. 134–149
📈 Citations: 56

5. Exploring disparities and variability in perceptions and self-reported colorectal cancer screening among three ethnic subgroups of US Blacks
📅 Year: 2010
✍️ Authors: C.K. Gwede, C.M. William, K.B. Thomas, W.L. Tarver, G.P. Quinn, et al.
📰 Oncology Nursing Forum, 37(5), 581
📈 Citations: 51

6. A randomized trial to compare a tailored web-based intervention and tailored phone counseling to usual care for increasing colorectal cancer screening
📅 Year: 2018
✍️ Authors: V.L. Champion, S.M. Christy, W. Rakowski, W.G. Gathirua-Mwangi, W.L. Tarver, et al.
📰 Cancer Epidemiology, Biomarkers & Prevention, 27(12), 1433–1441
📈 Citations: 35

7. The impact of health information technology on cancer care across the continuum: a systematic review and meta-analysis
📅 Year: 2016
✍️ Authors: W.L. Tarver, N. Menachemi
📰 Journal of the American Medical Informatics Association, 23(2), 420–427
📈 Citations: 35

8. Perceptions of colorectal cancer among three ethnic subgroups of US blacks: a qualitative study
📅 Year: 2011
✍️ Authors: C.K. Gwede, E. Jean-Francois, G.P. Quinn, S. Wilson, W.L. Tarver, K.B. Thomas, et al.
📰 Journal of the National Medical Association, 103(8), 669–680
📈 Citations: 35

9. Allostatic load: a framework to understand breast cancer outcomes in Black women
📅 Year: 2021
✍️ Authors: S. Obeng-Gyasi, W. Tarver, R.C. Carlos, B.L. Andersen
📰 NPJ Breast Cancer, 7(1), 100
📈 Citations: 34

10. Factors associated with adherence to mammography screening among insured women differ by income levels
📅 Year: 2018
✍️ Authors: W. Gathirua-Mwangi, A. Cohee, W.L. Tarver, A. Marley, E. Biederman, et al.
📰 Women’s Health Issues, 28(5), 462–469
📈 Citations: 34

Yana Zhang | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Assoc. Prof. Dr. Yana Zhang | Medicine and Dentistry | Best Researcher Award

Associate Professor from Department of Otolaryngology-Head and Neck Surgery, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China

Dr. Yana Zhang is an accomplished academic and researcher in the field of Otorhinolaryngology–Head and Neck Surgery, currently serving as an Associate Professor at the Third Affiliated Hospital of Sun Yat-sen University. She holds a Ph.D. from Tongji Medical College, Huazhong University of Science and Technology, China, and has completed a postdoctoral fellowship at Northwestern University, USA. With over a decade of research and clinical experience, Dr. Zhang has established herself as a leading figure in allergy and airway inflammation research. Since joining Sun Yat-sen University through the prestigious “Hundred Talents Program” in 2020, she has been spearheading multiple high-impact research projects. She has published more than 40 peer-reviewed articles in journals such as Nature Immunology, J Allergy Clin Immunol, J Exp Med, and Am J Respir Crit Care Med, many as first or corresponding author. Her research focuses on the molecular mechanisms underlying allergic inflammation and chronic rhinosinusitis. Dr. Zhang plays influential roles in several national academic and medical committees and is a regular reviewer for high-impact journals and research foundations. Her work is recognized for its translational value, aiming to improve treatment outcomes for patients with allergic diseases and ENT disorders.

Professional Profile

Education

Dr. Yana Zhang pursued her higher education in medicine and specialized in Otorhinolaryngology–Head and Neck Surgery. She earned her Ph.D. from Tongji Medical College at Huazhong University of Science and Technology in 2014, one of China’s most respected institutions in medical research. Her doctoral work focused on immunological mechanisms and inflammatory processes in chronic rhinosinusitis and other airway-related disorders, laying the groundwork for her later research. She subsequently enhanced her academic portfolio by undertaking postdoctoral training at Northwestern University in the United States from 2016 to 2020. This international experience enabled her to refine her research methods and establish collaborations with world-renowned immunologists and clinical scientists. Her training at Northwestern offered her exposure to advanced biomedical research techniques and allowed her to integrate global best practices into her work. This comprehensive academic background has provided her with a solid foundation to pursue advanced research in translational medicine, particularly in immune-mediated diseases of the upper respiratory tract. Her education reflects a blend of rigorous Chinese medical training and cutting-edge international research exposure, positioning her as a global scholar with a deep understanding of both clinical and experimental approaches.

Professional Experience

Dr. Zhang began her professional academic career after completing her Ph.D. in 2014. Following this, she undertook a postdoctoral fellowship at Northwestern University in the United States from 2016 to 2020, where she worked on translational research projects focused on immunoregulation and inflammatory diseases. This experience significantly expanded her research expertise and network. In 2020, she returned to China to join the Third Affiliated Hospital of Sun Yat-sen University as an Associate Professor through the university’s highly competitive “Hundred Talents Program.” In this role, she leads a dynamic research team working on inflammatory mechanisms in chronic rhinosinusitis and allergy-related comorbidities. Dr. Zhang also holds several influential academic appointments, including expert reviewer roles for the Ministry of Education and the National Natural Science Foundation of China. She serves on various national committees under the Chinese Medical Association and other professional bodies, contributing to policy, research direction, and academic evaluations. She also plays a key role in mentoring graduate students and guiding young researchers. Her multidisciplinary experience bridges clinical practice and molecular science, allowing her to translate laboratory findings into potential therapies for ENT and allergic conditions.

Research Interests

Dr. Yana Zhang’s research centers on immunological mechanisms and therapeutic strategies targeting eosinophilic inflammation and allergic airway diseases. Her work addresses chronic rhinosinusitis with nasal polyps (CRSwNP), a debilitating and recurring inflammatory disorder, and aims to unravel the molecular underpinnings of steroid resistance and epithelial barrier dysfunction. She has explored novel pathways involving fatty acids, IL-17A, vitamin D, and extracellular vesicles in allergic disease models. Her recent studies investigate the roles of epithelium-derived chemokines, Charcot-Leyden crystals, and immune checkpoints in modulating inflammation and tissue remodeling. Another central focus of her research is the interaction between environmental factors, such as air pollution, and the immunopathology of rhinitis and asthma. Dr. Zhang’s goal is to translate her laboratory findings into effective therapeutic strategies that can be applied in clinical settings. Her research also spans the field of immune metabolism, including succinate signaling and its effect on regulatory T cells, with implications for systemic autoimmune and allergic diseases. Her interdisciplinary work combines molecular biology, clinical otorhinolaryngology, and immunotherapy to address urgent healthcare challenges in allergy and airway inflammation.

Research Skills

Dr. Zhang is equipped with a comprehensive skill set in both clinical and molecular research. Her expertise includes cellular immunology, molecular biology, transcriptomics, histopathology, and translational medicine. She is proficient in designing and conducting in vivo and in vitro models of airway inflammation, including murine models of eosinophilic rhinosinusitis. She has extensive experience in flow cytometry, ELISA, immunohistochemistry, RNA sequencing, confocal microscopy, and CRISPR-Cas9 gene editing technologies. Her postdoctoral training at Northwestern University further enhanced her proficiency in advanced immunological assays, including Treg stability assays, metabolite analysis, and cell differentiation studies. Dr. Zhang is skilled in developing predictive models and statistical algorithms to interpret clinical outcomes and endotypes in allergic patients. Additionally, she collaborates with bioinformatics experts to analyze large datasets, facilitating biomarker discovery and patient stratification. Her capacity to bridge bench-side experimentation with clinical relevance makes her a leader in translational allergy research. Dr. Zhang’s multidisciplinary research environment allows her to apply both clinical acumen and lab-based expertise to uncover new therapeutic avenues in chronic inflammatory diseases.

Awards and Honors

Dr. Yana Zhang has received multiple accolades that reflect her scholarly excellence and leadership in biomedical research. Most notably, she was selected as a Young Top Talent under the Guangdong “Pearl River Talent Program” in 2022, a prestigious recognition for emerging scientific leaders in China. In 2020, she was recruited through the “Hundred Talents Program” at Sun Yat-sen University, a national initiative to attract top researchers to Chinese academic institutions. These honors underscore her scientific impact and potential to contribute to national innovation goals. In addition to these major recognitions, Dr. Zhang has been invited to serve as a grant reviewer for the National Natural Science Foundation of China, a testament to her credibility and leadership in the scientific community. She is also an expert evaluator for doctoral dissertations under the Ministry of Education. Her editorial and peer-review responsibilities for internationally reputed journals further reflect her standing in the academic field. Collectively, these awards and responsibilities highlight her commitment to advancing research, mentoring junior scientists, and shaping the future of otorhinolaryngology and immunology in China and beyond.

Conclusion

Dr. Yana Zhang stands out as an exceptional researcher and academic whose work has had a profound impact on the field of immunology and otorhinolaryngology. Her career reflects a harmonious blend of rigorous academic training, international experience, and a deep commitment to translational medicine. Through cutting-edge research on eosinophilic inflammation and allergic diseases, she has significantly advanced our understanding of the pathophysiological mechanisms underlying chronic airway disorders. Her contributions are well-documented through a robust portfolio of publications in top-tier scientific journals and her leadership in multiple national research projects. Furthermore, her active involvement in academic societies and committees showcases her dedication to the scientific community. Dr. Zhang’s efforts not only enhance clinical outcomes for patients but also influence national policy and research directions. Her vision of integrating basic research with clinical application makes her a key figure in developing personalized treatments for allergy and ENT disorders. With continued support and collaboration, Dr. Zhang is poised to make even greater strides in medical science and to serve as a role model for future researchers in China and globally.

Publications Top Notes

  1. Vitamin D impedes eosinophil chemotaxis via inhibiting glycolysis‑induced CCL26 expression in eosinophilic chronic rhinosinusitis with nasal polyps

  • Year: 2025

  • Authors: Weiqiang Huang, Yana Zhang, Yue Li, Junming Ma, Xia Li, Yanjie Jiang, Jianqi Wang, Haotian Wu, Xiaohong Chen, Zizhen Huang, Xifu Wu, Xiaoping Lai, Donglin Li, Lihong Chang, Gehua Zhang

2. Succinate drives gut inflammation by promoting FOXP3 degradation through a molecular switch

  • Year: 2025

  • Authors: Hai Wang, Danqing Hu, Yang Cheng, Qiong Gao, Kun Liu, Nikita L. Mani, Amy Y. Tang, Radhika Iyer, Beixue Gao, Leyu Sun, Qi Zhou, Qin Yu, Samuel E. Weinberg, Xiaoyu Zhang, Yingzi Cong, Parambir S. Dulai, Yana Zhang, Zheng Liu, Deyu Fang

 

 

Zachariah Chowdhury | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Dr. Zachariah Chowdhury | Medicine and Dentistry | Best Researcher Award

Professor, Dept Of Oncopathology from Mahamana Pandit Madan Mohan Malviya Cancer Centre (Tata Memorial Hospital) Varanasi, India

Dr. Zachariah Chowdhury is an accomplished academician, clinician, and researcher in the field of oncopathology, currently serving as the Professor and Officer-in-Charge of the Department of OncoPathology at the Mahamana Pandit Madan Mohan Malaviya Cancer Centre (MPMMCC) & Homi Bhabha Cancer Hospital (HBCH) in Varanasi, under the Tata Memorial Centre. With foundational training in MBBS and MD in Pathology from Assam Medical College and a UICC Fellowship in Oncopathology, he has demonstrated an unwavering commitment to excellence in pathology and cancer diagnostics. His extensive teaching background includes instruction at multiple academic levels, including DM, MD, MBBS, nursing, and laboratory technology programs. Dr. Chowdhury has amassed an impressive portfolio of over 50 peer-reviewed publications, addressing both common and rare oncological conditions, contributing significantly to the evolving understanding of oncopathology. He is recognized for his comprehensive approach that merges histopathology, cytopathology, hematopathology, and molecular pathology. As a reviewer, invited speaker, and research presenter at both national and international platforms, he exemplifies the qualities of a dedicated and visionary medical researcher. His contributions to both clinical practice and research make him a pivotal figure in the Indian medical community and a strong candidate for national and international honors in the field of cancer pathology.

Professional Profile

Education

Dr. Chowdhury’s academic journey began with outstanding scholastic achievements, securing the 5th rank in his Higher Secondary School Examination from Cotton College, Guwahati, with a remarkable 83.6% score. He earned his MBBS from Assam Medical College under Dibrugarh University in 2004, ranking 2nd in his final examinations. His dedication to medical sciences continued with an MD in Pathology in 2011 from the same institution, where he again demonstrated academic excellence by clearing all examinations in his first attempt. Complementing his postgraduate training, Dr. Chowdhury was awarded the prestigious UICC/Dr. Praful Desai Fellowship in Oncopathology at Tata Memorial Centre, Mumbai, where he further honed his expertise in histopathology, cytopathology, and molecular diagnostics. Additionally, he underwent advanced training in molecular pathology at Tata Medical Centre, Kolkata, and Tata Memorial Centre, Parel, reinforcing his foundation in modern cancer diagnostics. His academic credentials are supported by multiple merit certificates from the Assam Higher Secondary Education Council, All Assam Students Union, and Assam Medical College, highlighting consistent academic distinction from secondary education through to his postgraduate years. This strong educational foundation has enabled Dr. Chowdhury to effectively lead both clinical and academic responsibilities in the field of oncopathology.

Professional Experience

Dr. Zachariah Chowdhury has accumulated rich and diverse professional experience across multiple prestigious institutions. He began his teaching career as a Senior Resident Doctor at the North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences (NEIGRIHMS), Shillong, where he served for three years post-MD, laying a strong foundation in clinical pathology and academic instruction. Currently, he serves as Professor and Officer-in-Charge of the Department of OncoPathology at MPMMCC & HBCH in Varanasi, both units under the Tata Memorial Centre. In this leadership role, he oversees academic training and diagnostic services in a high-volume cancer care setting. Dr. Chowdhury’s responsibilities include teaching DM (OncoPathology), MD (Pathology), MBBS, nursing, and laboratory science students in both theory and laboratory environments. His clinical expertise encompasses a wide spectrum, including histopathology, cytopathology, hematopathology, molecular diagnostics, clinical pathology, renal pathology, immunopathology, and blood banking. Additionally, he plays an active role in quality assurance programs within the diagnostic laboratory. Beyond his hospital commitments, he contributes to academia as a peer reviewer for multiple reputed medical journals and participates in national and international conferences as a speaker, panelist, and faculty. This blend of academic, clinical, and leadership experience underscores his stature as a seasoned medical professional.

Research Interest

Dr. Chowdhury’s research interests center around oncopathology with a multidisciplinary focus that integrates histopathology, molecular pathology, cytopathology, and hematopathology. His scholarly work investigates a wide range of oncological conditions, including breast cancer, thyroid lesions, ovarian tumors, pediatric malignancies, head and neck cancers, and hematolymphoid neoplasms. A key area of his research explores the diagnostic challenges and spectrum of rare tumors such as salivary gland neoplasms, solitary fibrous tumors, and angiosarcomas, with a special emphasis on cytohistological correlations and immunomorphological profiling. Additionally, he has contributed to understanding emerging themes like artificial intelligence in histopathology and the role of molecular diagnostics in rare malignancies. His recent studies include real-world clinical data on metastatic cancers and chemotherapy outcomes, bridging clinical practice with diagnostic research. Dr. Chowdhury’s commitment to evidence-based pathology is evident in his methodical approach to publishing both retrospective reviews and case-based literature, offering valuable insights to the global oncopathology community. His collaborations with multidisciplinary teams from oncology, radiology, and surgery reflect his integrative research philosophy. By focusing on both common diagnostic patterns and rare, underreported entities, his work not only advances academic pathology but also significantly contributes to clinical decision-making and patient outcomes.

Research Skills

Dr. Zachariah Chowdhury brings to the research landscape a comprehensive skill set encompassing classical and modern pathology techniques. He is proficient in histological examination, cytopathological evaluations (including FNAC and core biopsies), hematopathology analyses, and cutting-edge molecular diagnostics. His training at leading cancer centers like Tata Memorial Centre and Tata Medical Centre has equipped him with practical expertise in PCR, FISH, and immunohistochemistry techniques—essential tools in the molecular characterization of tumors. He also has expertise in immunomorphology and has applied these skills across a broad range of clinical cases, from pediatric cancers to high-grade lymphomas and soft tissue tumors. Dr. Chowdhury is also skilled in academic writing and statistical analysis, as evidenced by his extensive publication record across peer-reviewed indexed journals. His systematic approach to clinical audits, retrospective analyses, and diagnostic algorithm development further highlight his research rigor. Additionally, he has contributed to AI applications in cancer diagnosis, showcasing adaptability to new technologies. His experience in organizing research presentations and mentoring junior faculty and students also reflects strong leadership and team management skills within research settings. Altogether, his multidimensional research skills strongly align with the goals of translational oncology and precision medicine.

Awards and Honors

Dr. Chowdhury’s illustrious career has been recognized with numerous awards and honors, validating his significant impact in the field of pathology. Among the most notable are the Bharat Gaurav Puraskar (2023) and the Jewel of India Award (2024), both conferred by the KTK Outstanding Achievers and Education Foundation, New Delhi, for his exemplary contributions to pathology and medical education. During his academic years, he received multiple certificates of merit for academic excellence, including top ranks in both secondary and medical school examinations. His postgraduate performance earned him a Certificate of Merit from Assam Medical College. As a faculty member and researcher, he has consistently excelled in academic events, winning the first prize in Oral Paper Presentation at the 5th International Pediatric Pathology Conference (2022) and the Poster Presentation at NEIGRIHMS Annual Research Day (2018). His early career awards also include the North Eastern Council (NEC) Scholarship for MBBS, which supported his foundational medical education. Beyond these, his recognition extends to being a respected reviewer for multiple journals, and his frequent roles as invited speaker and panelist at various conferences. These accolades reflect both peer and institutional acknowledgment of his enduring impact on medical research and education.

Conclusion

Dr. Zachariah Chowdhury exemplifies the ideals of a clinician-scientist dedicated to excellence in oncopathology. With a firm grounding in both classical pathology and modern diagnostic innovations, he bridges the gap between histological diagnosis and translational cancer research. His career reflects a rare combination of clinical acumen, academic mentorship, research productivity, and institutional leadership. Through his prolific authorship of over 50 peer-reviewed publications, he contributes actively to the global understanding of complex and rare oncological entities. His commitment to education is evident in his multi-level teaching engagements and ongoing mentorship of pathology trainees. Dr. Chowdhury’s recognition through multiple national honors and academic awards further substantiates his role as a leading figure in cancer pathology in India. While already operating at a high level of academic and clinical distinction, future initiatives such as enhanced international collaborations, grant-funded research, and patent development would elevate his profile even further. Overall, Dr. Chowdhury represents a distinguished and highly qualified candidate for any recognition aimed at honoring pathologists and researchers who make substantial contributions to medical science, and particularly, to the evolving discipline of oncopathology.

Publications Top Notes

1. The many faces of ovarian sex cord stromal tumors: a clinicopathological analysis at a tertiary cancer center in North India

  • Year: 2025

  • Authors: Chowdhury Z, Agrawal S, Gupta S, Rai S, Jethani R, Saha S, Ranjan R, Pal A

  • Journal: Surgical and Experimental Pathology

2. The Myriad Spectrum of Salivary Gland Lesions: Cytohistological Correlation on Fine Needle Aspiration Cytology, Core Needle Biopsy, and Resections in a 5-Year Single Institutional Experience of North India

  • Year: 2025

  • Authors: Chowdhury Z, Majumdar P, Narain S, Lamba K

  • Journal: Diagnostic Cytopathology

3. ALK-positive large B-cell lymphoma: A study of six cases from an oncopathology center in North India

  • Year: 2025

  • Authors: Verma A, Chowdhury Z, Singh A, Kant A, Yadav A, Patne SCU

  • Journal: Indian Journal of Pathology and Microbiology

4. Cyto-Histomorphological Analysis of Thyroid Lesions and Risk Assessment of Malignancy/Neoplasia: Insights from a North Indian Tertiary Oncology Center

  • Year: 2025

  • Authors: Haiyat S, Chowdhury Z, Rudra Pal P, Patne S, Dhal I, Paul P

  • Journal: Cureus

5. An Analysis of Pediatric Round Cell Tumors Highlighting the Spectrum of Differential Diagnosis – A Single Center Experience and Systematic Review of Literature

  • Year: 2025

  • Authors: Dhal I, Lali BS, Rai H, Chowdhury Z, Patne S, Tripathi P, Saha S

  • Journal: International Journal of Scientific Studies

6. Real-world data on trastuzumab emtansine (TDM1) efficacy and safety: Results of a single-centre retrospective study of HER2-positive metastatic breast cancer patients

  • Year: 2025

  • Authors: Gupta A, Sansar B, Mishra BK, Khan A, Singh A, Upadhyay A, Chowdhury Z, Patne S, Tripathi M, et al.

  • Journal: Scientific Reports

7. Triple Oral Metronomic Chemotherapy Versus Chemotherapy of Physician Discretion After Failure of Platinum-Based Therapy in Advanced Head and Neck Cancer: A Phase III Randomized Study (METRO-CHASE Study)

  • Year: 2025

  • Authors: Kapoor A, Gupta A, Sansar B, Mishra BK, Gupta P, Singh A, Upadhyay A, Kashyap L, Pal A, Kumar A, Nanda SS, Mukherji A, Kapoor AR, Pradhan S, Mishra A, Chowdhury Z, Patne S, Dhal I, Singh N, et al.

  • Journal: JCO Global Oncology

8. Exploring Solitary Fibrous Tumors at a Tertiary Cancer Center: Clinicopathological and Immunomorphologic Profile

  • Year: 2024

  • Authors: Chowdhury Z, Mishrikotkar S, Nehra P, Patne S, Tripathi M

  • Journal: Cureus

9. A Review of the Applications of Artificial Intelligence in Histopathology

  • Year: 2024

  • Authors: Kandarpa S, Chowdhury Z, Pal PR, Rajput K, Saraf SA

  • Journal: Journal of Cancer Research Reviews & Reports

10. Outcomes of De Novo Oligometastatic Breast Cancer Treated With Surgery of Primary and Metastasis Directed Radiotherapy

  • Year: 2024

  • Authors: Pujari L, Suresh A, Chowdhury Z, Pradhan S, Tripathi M, Gupta A, Singh P, Giridhar P, Kapoor AR, Shinghal A, Sansar B, Mv M

  • Journal: American Journal of Clinical Oncology

 

Nobuhiro Takahashi | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Dr. Nobuhiro Takahashi | Medicine and Dentistry | Best Researcher Award

Dermatologist from Tokai University School of Medicine, Japan

Dr. Nobuhiro Takahashi is a dedicated clinical professional specializing in dermatology, with a primary focus on inflammatory skin diseases. Currently serving as a Clinical Assistant in the Department of Dermatology at Tokai University Hospital, Kanagawa, Japan, Dr. Takahashi actively participates in both clinical practice and academic training. He has demonstrated a strong commitment to advancing patient care in outpatient dermatology. His work reflects a growing interest in combining clinical insights with research opportunities. With a solid foundation in medical education and practical experience, Dr. Takahashi shows promise for contributing significantly to dermatological research in the future.

Professional Profile

Education

Dr. Nobuhiro Takahashi completed his medical degree at Tokai University School of Medicine, Japan, graduating in March 2020. His academic training provided him with a comprehensive understanding of medical sciences, with a particular interest in dermatology developing during his studies. The rigorous curriculum at Tokai University laid the groundwork for his clinical reasoning, diagnostic skills, and patient management techniques. His education emphasized both theoretical knowledge and practical application, preparing him effectively for postgraduate clinical training and his current clinical role. Dr. Takahashi’s education continues to support his professional development and potential future contributions to clinical research.

Professional Experience

Dr. Takahashi began his professional journey as a Clinical Resident at Tokai University Hospital, where he completed a two-year postgraduate clinical training program from April 2020 to March 2022. This experience allowed him to build strong diagnostic and treatment skills across multiple medical disciplines. Since April 2022, he has been serving as a Clinical Assistant in the Department of Dermatology at Tokai University. In this role, he focuses on outpatient clinical dermatology and academic training, working closely with specialists to manage a variety of dermatological conditions. His current responsibilities allow him to blend clinical service with ongoing professional growth.

Research Interest

Dr. Takahashi’s primary research interests center around dermatology, particularly the study and management of inflammatory skin diseases. He is focused on improving clinical outcomes and advancing therapeutic strategies for these complex skin conditions. His exposure to diverse patient cases in an outpatient setting provides valuable clinical observations that can guide his research direction. While his current profile does not extensively detail research projects or publications, his interest in bridging clinical practice with academic research is evident. Dr. Takahashi is well-positioned to contribute to future dermatological studies that address common and challenging skin disorders.

Research Skills

Dr. Takahashi has developed a strong set of clinical and observational skills through his extensive outpatient dermatology practice. His ability to diagnose, monitor, and manage various skin conditions equips him with firsthand clinical insights essential for relevant and impactful research. Although specific laboratory or advanced research techniques are not detailed in his profile, his clinical experience supports potential development in clinical research methodologies, case study analysis, and patient-centered research. His ongoing academic training is expected to enhance his research capabilities further, enabling him to contribute to clinical trials and evidence-based dermatology studies.

Award and Honors

At this stage of his career, Dr. Takahashi has not yet received formal awards or honors in the field of dermatology or medical research. His professional achievements thus far reflect his dedication to clinical practice and academic growth. As he continues to develop his research portfolio and engage in scholarly activities, there is significant potential for him to earn recognition in the future. Participation in conferences, collaborative research, and contributions to peer-reviewed publications will likely pave the way for future awards and academic honors that acknowledge his efforts in advancing dermatological science.

Conclusion

In conclusion, Dr. Nobuhiro Takahashi is an emerging clinical dermatologist with a promising future in research. His solid educational background, hands-on clinical experience, and keen interest in inflammatory skin diseases demonstrate his dedication to the field. Although he currently has limited research output and formal recognitions, his trajectory indicates potential for future contributions to dermatological science. With continued clinical engagement, research involvement, and academic participation, Dr. Takahashi can develop into a respected researcher who significantly impacts both patient care and dermatological research. His career is well-positioned for continued growth and achievement.

Publication Top Note

  1. Title: A Case of Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma
  • Journal: JEADV Clinical Practice
  • Year: 2025

 

Jingwen Zhang | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Dr. Jingwen Zhang | Medicine and Dentistry | Best Researcher Award

Research Fellow from The University of Melbourne, Australia

Dr. Jingwen Zhang is an emerging epidemiologist specializing in respiratory health, particularly chronic cough in adults. Currently serving as a Research Fellow at the Allergy and Lung Health Unit, The University of Melbourne, she has demonstrated a strong commitment to impactful public health research. With academic training in clinical medicine, public health, and epidemiology, Dr. Zhang brings a unique multidisciplinary perspective to her work. Her research is recognized at both national and international levels, having received prestigious scholarships, competitive grants, and multiple awards for her presentations. She has published extensively and has provided significant contributions as a peer reviewer for leading journals, including The Lancet and New England Journal of Medicine. Beyond her research, Dr. Zhang is actively engaged in teaching, mentoring postgraduate students, organizing scientific meetings, and participating in collaborative initiatives that aim to advance respiratory health research. Her work has attracted considerable media attention, reflecting its relevance to the broader public. Dr. Zhang’s dedication to improving respiratory health outcomes, her leadership in the research community, and her drive for continuous professional development make her a distinguished figure in the field of epidemiology with great potential for future leadership on a global scale.

Professional Profile

Education

Dr. Jingwen Zhang’s academic journey is a blend of excellence in clinical and public health disciplines. She is currently pursuing her Doctor of Philosophy (Epidemiology) at The University of Melbourne, Australia, from 2019 to 2024. Her research focuses on the epidemiology of adult chronic cough, supported by the prestigious University of Melbourne and China Scholarship Council Joint Scholarship. This scholarship covers her tuition fees and provides a substantial living stipend, reflecting the competitiveness of her candidature. Prior to this, she earned a Master of Public Health with First Class Honours from The University of Melbourne in 2018, showcasing her early academic excellence in the public health domain. Her undergraduate degree in Clinical Medicine, obtained from Qingdao University, China, in 2016, provided her with a strong foundation in medical sciences. This diverse educational background equips her with critical clinical insights and advanced epidemiological skills, making her uniquely capable of translating clinical problems into population-based research solutions. Throughout her studies, Dr. Zhang has actively pursued advanced training and upskilling workshops in contemporary epidemiology, clinical trials, and causal inference, further enhancing her scientific competence and professional readiness to address complex public health issues.

Professional Experience

Dr. Jingwen Zhang’s professional journey is marked by progressive research and academic responsibilities. Since 2023, she has been working as a Research Fellow at the Allergy and Lung Health Unit, The University of Melbourne, contributing to cutting-edge respiratory health research. Between 2021 and 2023, she served as a Research Assistant at the same institution, where she supported numerous projects in chronic cough and lung health epidemiology. Her experience extends to academic teaching as a casual tutor at the Centre for Epidemiology and Biostatistics in 2021, where she taught core epidemiology subjects and developed teaching materials for advanced courses. Earlier in her career, in 2016, she worked as a teacher and administrative officer at Amio International Education in China, which provided her with valuable organizational and communication skills. Dr. Zhang’s career also reflects her active participation in scientific committee meetings, leadership in organizing collaborative research initiatives, and volunteer contributions at major scientific conferences. These experiences demonstrate her dedication to academic service and her capacity for multi-tasking across research, teaching, mentoring, and community engagement. Her sustained involvement in both the academic and clinical research environment showcases her readiness to contribute at a higher level within the international research community.

Research Interest

Dr. Jingwen Zhang’s primary research interest lies in the epidemiology of chronic cough and its broader implications for respiratory health. Her doctoral research focuses on understanding chronic cough phenotypes and identifying occupational and environmental risk factors associated with different cough types among middle-aged adults. She is particularly interested in how long-term exposure to air pollution and other environmental factors contribute to chronic respiratory conditions. Her work also explores the epidemiology of asthma-COPD overlap and interventions to improve lung function among adults and children. Dr. Zhang’s research interests extend to the development of evidence-based clinical and public health strategies for improving lung health outcomes. Additionally, she is committed to applying advanced epidemiological methods, including causal inference, longitudinal data analysis, and systematic reviews, to address pressing public health issues. She is passionate about translating complex research findings into actionable insights that can shape policy, clinical practice, and public awareness. Dr. Zhang is also actively involved in collaborative cohort studies such as TAHS and PRECURSOR, which provide large-scale data for respiratory health research. Through her multi-dimensional research focus, Dr. Zhang aims to bridge the gap between clinical observations and population health interventions, ultimately improving respiratory disease management and prevention strategies.

Research Skills

Dr. Jingwen Zhang possesses a diverse and highly applicable skill set that supports her work in epidemiology and respiratory health research. She is proficient in advanced epidemiological study designs, data cleaning, and statistical analysis, with strong expertise in using statistical software such as R and REDCap. Dr. Zhang has completed specialized training in causal inference, clinical trials, reproducible research, and contemporary epidemiology, equipping her with the methodological tools necessary for high-impact research. She has substantial experience in data management, including cleaning and processing large cohort datasets, spirometry data, and address tracking for environmental exposure studies. Dr. Zhang is also skilled in systematic reviews, meta-analyses, and longitudinal study methodologies. Additionally, she has developed teaching skills through her involvement in tutorials, course material development, and student assessment. Dr. Zhang’s experience extends to manuscript preparation, scientific communication, and peer reviewing for high-ranking journals. Her organizational capabilities are evident through her role in coordinating large research initiatives, managing academic social media platforms, and hosting scientific meetings. With strong analytical thinking, attention to detail, and effective communication, Dr. Zhang’s research skills enable her to contribute meaningfully to multidisciplinary teams and deliver impactful epidemiological research outcomes.

Awards and Honors

Throughout her academic and professional journey, Dr. Jingwen Zhang has received several prestigious awards and honors that recognize her contributions to respiratory epidemiology. In 2022, she won the Best Poster Award at the Thoracic Society of Australia and New Zealand Annual Scientific Meeting for her work on occupational risks associated with novel cough phenotypes. In 2023, she received the Golden Prize at the 4th International Cough Conference for her oral presentation on the associations between air pollutants and cough types in middle-aged adults, a recognition that included funding for accommodation and travel. Dr. Zhang was awarded the University of Melbourne and China Scholarship Council Joint Scholarship, a highly competitive program covering both tuition fees and a generous living stipend for her Ph.D. studies. She also secured the PHIRST Grant in 2021 and multiple travel grants in 2024, including the TSANZ Janet Elder International Travel Award. Dr. Zhang’s excellence extends beyond awards, as she has been invited to review manuscripts for leading journals like The Lancet, Thorax, New England Journal of Medicine, and European Respiratory Journal, showcasing her growing influence in the research community. These accolades reflect her scientific rigor, leadership potential, and dedication to improving public health outcomes.

Conclusion

Dr. Jingwen Zhang exemplifies the qualities of an outstanding early-career researcher with a promising future in the field of epidemiology and respiratory health. Her strong academic foundation, research productivity, and active participation in academic service position her as a rising leader in public health research. Dr. Zhang’s work addresses a critical gap in chronic cough epidemiology and contributes valuable knowledge with the potential to influence clinical guidelines and public health policies. She has successfully combined rigorous research with impactful community engagement and international scientific dissemination. Her role as a mentor and organizer further demonstrates her leadership and commitment to building collaborative research environments. With further opportunities to expand international collaborations, increase first-author publications in top-tier journals, and lead larger research grants, Dr. Zhang is well-positioned to achieve global recognition in her field. Her comprehensive skill set, exceptional dedication, and passion for improving respiratory health outcomes make her a highly deserving candidate for prestigious research awards and continued academic advancement. Dr. Zhang’s career trajectory reflects not only her scientific excellence but also her potential to drive meaningful change in public health both nationally and internationally.

Publications Top Notes

1. Associations Between Occupational Exposures and Cough Subclasses Among Middle‐Aged Australians

  • Authors: Jingwen Zhang, Jennifer L. Perret, Dinh S. Bui, Sheikh M. Alif, Michael J. Abramson, Anne B. Chang, Hans Kromhout, Garun S. Hamilton, Paul S. Thomas, Bircan Erbas, et al.

  • Year: 2025

2. Chronic Bronchitis in Children and Adults: Definitions, Pathophysiology, Prevalence, Risk Factors, and Consequences

  • Authors: Jingwen Zhang, Danielle F. Wurzel, Jennifer L. Perret, Caroline J. Lodge, E. Haydn Walters, Shyamali C. Dharmage

  • Year: 2024

3. Association of Novel Adult Cough Subclasses With Clinical Characteristics and Lung Function Across Six Decades of Life in a Prospective, Community-Based Cohort in Australia: An Analysis of the Tasmanian Longitudinal Health Study (TAHS)

  • Authors: Jingwen Zhang, Caroline J. Lodge, E. Haydn Walters, Anne B. Chang, Dinh S. Bui, Adrian J. Lowe, Garun S. Hamilton, Paul S. Thomas, Chamara V. Senaratna, Alan L. James, et al.

  • Year: 2024

4. A Review of the Role of Pollen in COVID-19 Infection

  • Authors: Nur Sabrina Idrose, Jingwen Zhang, Caroline J. Lodge, Bircan Erbas, Jo A. Douglass, Dinh S. Bui, Shyamali C. Dharmage

  • Year: 2023

5. Risk Factors for Chronic Cough in Adults: A Systematic Review and Meta‐Analysis

  • Authors: Jingwen Zhang, Jennifer L. Perret, Anne B. Chang, Nur S. Idrose, Dinh S. Bui, Adrian J. Lowe, Michael J. Abramson, E. Haydn Walters, Caroline J. Lodge, Shyamali C. Dharmage

  • Year: 2022

6. Serum Cytokine Concentrations and Asthma Persistence to Middle Age

  • Authors: Jingwen Zhang, Eugene H. Walters, Mimi L. K. Tang, Adrian J. Lowe, Caroline J. Lodge, Dinh Bui, Rangi Kandane‐Rathnayake, Bircan Erbas, Garun S. Hamilton, Bruce R. Thompson, et al.

  • Year: 2020

Susumu Eguchi | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Prof. Susumu Eguchi | Medicine and Dentistry | Best Researcher Award

Professor and Chairman from Nagasaki University Graduate School of Biomedical Sciences, Japan

Dr. Susumu Eguchi, M.D., Ph.D., F.A.C.S., F.E.B.S., is a globally recognized expert in the field of liver transplantation, hepatobiliary (HPB) surgery, and regenerative medicine. As a Professor and Chairman at the Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Dr. Eguchi has demonstrated outstanding leadership in both clinical and academic arenas. His medical journey is marked by international exposure, significant research contributions, and a wide array of prestigious editorial appointments. He has actively shaped the advancement of liver surgery, particularly focusing on liver regeneration and hepatocyte-based therapies. Dr. Eguchi’s dedication extends beyond national boundaries, with ongoing collaborations as a visiting professor in China and Kazakhstan, strengthening cross-cultural medical education and research. His active participation in hospital management, international medical center leadership, and nuclear disaster preparedness showcases his multifaceted expertise. Additionally, his editorial influence in several leading surgical and transplantation journals underlines his authority and commitment to knowledge dissemination. Throughout his distinguished career, Dr. Eguchi has significantly contributed to the global medical community and is highly regarded for his ability to combine innovative research with practical surgical excellence. His holistic approach and deep impact in the field make him a prominent figure deserving international recognition.

Professional Profile

Education

Dr. Susumu Eguchi’s educational journey is marked by rigorous academic training and international exposure that shaped his expertise in surgery and transplantation. He graduated from the Nagasaki University School of Medicine in 1992, where he developed a solid foundation in medical sciences. His dedication to deepening his knowledge led him to pursue a Ph.D. at the Nagasaki University Graduate School of Biomedical Sciences, Department of Surgery, from April 1994 to March 1998. This doctoral program was pivotal in advancing his surgical and research competencies, particularly in the hepatobiliary and liver transplantation domains. His international perspective was further broadened during his time at Cedars-Sinai Medical Center in the United States from 1994 to 1997, where he gained valuable experience in surgical research. Dr. Eguchi’s education provided him with a comprehensive blend of clinical, academic, and research-based learning that later translated into his significant contributions to the surgical field. The integration of both Japanese and Western medical training environments equipped him with a unique ability to lead innovative research and clinical practices. His academic progression reflects a consistent pursuit of excellence and positioned him to become an influential leader in liver transplantation and regenerative medicine.

Professional Experience

Dr. Susumu Eguchi has an extensive and distinguished professional career spanning over three decades, characterized by leadership roles in clinical practice, international collaborations, and academic governance. His journey began as a surgical trainee at Nagasaki University Hospital, and he further honed his skills at Cedars-Sinai Medical Center, focusing on surgical research. He has served in key positions such as Chief of Surgery at various hospitals, including National Tsushima Hospital and Nakatsushima Hospital. His international clinical fellowship at Groningen University Hospital in the Netherlands specialized in liver transplantation and hepatobiliary surgery, deepening his expertise in these fields. Since 2012, he has been a Professor at Nagasaki University Graduate School of Biomedical Sciences, where he also took on administrative roles, including Deputy Hospital Director and Director of the International Medical Center and Transplant Center. His global influence is evident through his visiting professorship at Guangzhou First Municipal People’s Hospital and Professor Emeritus roles at prestigious institutions in Kazakhstan and China. Dr. Eguchi’s career reflects a perfect balance of surgical excellence, academic leadership, and international outreach. His continuous involvement in both patient care and research highlights his dedication to advancing surgical techniques and improving patient outcomes globally.

Research Interest

Dr. Susumu Eguchi’s research interests are centered around advancing liver transplantation, hepatobiliary surgery, liver regeneration, and regenerative medicine. His work has significantly contributed to the development of liver surgery techniques and the enhancement of liver transplantation outcomes. A major focus of his research involves hepatocyte-based therapy, exploring the potential of regenerative treatments to restore liver function and improve long-term survival rates for patients. Dr. Eguchi is also deeply invested in liver regeneration studies, aiming to unravel cellular and molecular mechanisms that can accelerate or support liver recovery after surgery or damage. His commitment to hepatobiliary and pancreatic (HPB) surgery research integrates both clinical advancements and innovative therapies, addressing complex surgical challenges. Additionally, Dr. Eguchi has shown interest in disaster response and medical preparedness, applying his medical leadership to nuclear disaster situations. His broad research spectrum allows him to contribute to multidisciplinary fields, including surgical innovation, organ preservation, and post-operative recovery strategies. With his global perspective and cross-institutional collaborations, Dr. Eguchi continues to drive progress in improving surgical outcomes and patient care. His pioneering research offers promising solutions in regenerative medicine and solid organ transplantation, pushing the boundaries of modern surgical practices.

Research Skills

Dr. Susumu Eguchi possesses a wide range of research skills that reflect his technical mastery and innovative approach in the field of surgery and transplantation. He is highly skilled in complex liver surgery, hepatobiliary surgical techniques, and organ transplantation procedures. His research capabilities encompass hepatocyte-based therapy development, liver regeneration studies, and regenerative medicine applications. Dr. Eguchi is adept at designing clinical trials, managing multi-institutional research projects, and applying translational research principles to bridge laboratory findings with patient care improvements. His leadership in surgical research has been recognized internationally, contributing to advancements in both surgical methodologies and post-operative patient management. Moreover, Dr. Eguchi demonstrates strong skills in cross-cultural medical collaboration, contributing to the development of global treatment standards. His editorial roles across multiple high-impact journals also indicate his proficiency in critical peer review, scientific writing, and knowledge dissemination. He is experienced in guiding surgical teams, mentoring young researchers, and overseeing international research initiatives. Additionally, his involvement in disaster preparedness reflects his ability to integrate surgical expertise with public health strategies. Dr. Eguchi’s exceptional surgical and research skills collectively position him as a leading figure in the evolution of liver surgery and transplantation.

Awards and Honors

Dr. Susumu Eguchi has received numerous prestigious certifications and honors throughout his distinguished career, which underline his excellence and global recognition in the surgical community. He is a Fellow of the American College of Surgeons (F.A.C.S.), a Fellow of the European Board of Surgery (F.E.B.S.), a Fellow of the International College of Surgeons (F.I.C.S.), and has been recognized as an IASGO Fellow (FASGO) since 2023. His leadership and contributions have earned him honorary titles, such as Professor Emeritus at both Syzganovs’ National Scientific Centre of Surgery in Kazakhstan and The Second Affiliated Hospital to Nanchang University in China. Dr. Eguchi’s exceptional academic contributions are further demonstrated through his numerous editorial appointments in influential journals, including Transplantation, SURGERY, Hepatology Research, Journal of Hepato-Biliary-Pancreatic Science, and Annals of Gastroenterological Surgery. His editorial influence reflects his standing as an expert in the field and his commitment to advancing global surgical knowledge. These accolades not only validate his exceptional skills and research contributions but also emphasize his role as an international leader and innovator in liver transplantation and hepatobiliary surgery.

Conclusion

In conclusion, Dr. Susumu Eguchi is an outstanding and highly accomplished surgeon, educator, and researcher whose contributions to the fields of liver transplantation, hepatobiliary surgery, and regenerative medicine have had a profound impact both in Japan and internationally. His career is marked by an exceptional blend of clinical excellence, academic leadership, and global collaboration. Dr. Eguchi’s extensive research into liver regeneration and hepatocyte-based therapy offers significant advancements in surgical techniques and patient care. His ability to successfully bridge international academic relationships, lead hospital departments, and manage disaster preparedness initiatives highlights his multifaceted expertise. His prestigious fellowships, editorial leadership roles, and international professorships further attest to his global influence and professional recognition. Although future efforts to showcase quantitative research impact, such as citation metrics, could further solidify his academic profile, his achievements to date are exemplary. Dr. Eguchi continues to inspire the next generation of surgeons and researchers through his innovative work, extensive mentorship, and dedication to improving liver surgery outcomes worldwide. Based on his contributions and leadership, he is an exceptional candidate for recognition as a leading researcher and an ideal recipient of the Best Researcher Award.

Publications Top Notes

1. Transplantation of chemically induced liver progenitors in Nagase analbuminemic rats under liver regenerative stimulus

Authors: Masayuki Fukumoto, Akihiko Soyama, Daisuke Miyamoto, Takanobu Hara, Hajime Matsushima, Hajime Imamura, Mampei Yamashita, Tomohiko Adachi, Kengo Kanetaka, Susumu Eguchi
Year: 2025

2. Association Between Distance to the Transplant Center and Survival Following Living Donor Liver Transplantation

Authors: Hajime Matsushima, Akihiko Soyama, Takanobu Hara, Ayaka Kinoshita, Takashi Hamada, Kazushige Migita, Ayaka Satoh, Hajime Imamura, Tomohiko Adachi, Susumu Eguchi
Year: 2025

3. Effect on short‐term outcomes of the COVID‐19 pandemic following laparoscopic distal gastrectomy and low anterior resection for gastric and rectal cancer: A retrospective study using the Japanese National Clinical Database, 2018–2022

Authors: Masafumi Inomata, Hideki Endo, Tomonori Akagi, Hidefumi Shiroshita, Shigeki Yamaguchi, Susumu Eguchi, Norihito Wada, Yukinori Kurokawa, Yosuke Seki, Yoshiharu Sakai, et al.
Year: 2025

4. Limitations of the proposed lymph node classification in intrahepatic cholangiocarcinoma

Author: Susumu Eguchi
Year: 2025

5. Annual report on National Clinical Database 2021 for gastroenterological surgery in Japan

Authors: Sunao Ito, Arata Takahashi, Hideki Ueno, Shuji Takiguchi, Yoshiki Kajiwara, Yoshihiro Kakeji, Susumu Eguchi, Takanori Goi, Akio Saiura, Akira Sasaki, et al.
Year: 2025

6. Histopathological Downgrading of Borderline Phyllodes Tumor in a Young Patient Following Chemotherapy: A Case Report

Authors: Yuki Hara, Rin Yamaguchi, Ryota Otsubo, Ayako Fukushima, Eiko Inamasu, Momoko Akashi, Michi Morita, Sayaka Kuba, Susumu Eguchi, Keitaro Matsumoto
Year: 2024

7. Efficacy of chemically induced human hepatic progenitor cells from diseased liver against nonalcoholic steatohepatitis model

Authors: Daisuke Miyamoto, Kunihito Matsuguma, Kazuhiro Nagai, Takayuki Miyoshi, Takanobu Hara, Hajime Matsushima, Akihiko Soyama, Takahiro Ochiya, Yasushi Miyazaki, Susumu Eguchi
Year: 2024

8. Current status and future perspectives of robotic liver surgery

Authors: Akihiko Soyama, Takashi Hamada, Tomohiko Adachi, Susumu Eguchi
Year: 2024

9. Essential updates 2022/2023: A review of current topics in robotic hepatectomy

Authors: Tomohiko Adachi, Takanobu Hara, Hajime Matsushima, Akihiko Soyama, Susumu Eguchi
Year: 2024

10. Short‐term outcomes after liver resection with vascular reconstruction: Results from a study with the National Clinical Database of Japan

Authors: Akihiko Soyama, Hiroyuki Yamamoto, Susumu Eguchi, Atsushi Nanashima, Yoshihiro Kakeji, Yuko Kitagawa, Masafumi Nakamura, Itaru Endo
Year: 2024

Young Un Choi | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Assist. Prof. Dr. Young Un Choi | Medicine and Dentistry | Best Researcher Award

Assistant Professor from WonJu Severance Christian Hospital, South Korea

Dr. Young Un Choi is a highly experienced Clinical Assistant Professor at Yonsei University Wonju College of Medicine, specializing in trauma surgery, emergency medicine, and critical care. Throughout his distinguished medical career, Dr. Choi has been committed to advancing trauma management and emergency surgical procedures through both clinical practice and academic research. He has accumulated extensive hands-on experience working in various hospitals, including service in international medical cooperation programs. His clinical expertise is complemented by his active engagement in numerous national and international trauma, surgery, and emergency care societies. Dr. Choi has published extensively in peer-reviewed journals, contributing significantly to the understanding of trauma mechanisms, surgical interventions, and critical care outcomes. His dedication to continuous learning is evident through his participation in globally recognized trauma certification courses and advanced surgical training programs. Dr. Choi’s research has had a positive impact on the development of trauma care protocols in South Korea, particularly in the establishment and improvement of regional trauma centers. His work addresses critical healthcare challenges, aiming to reduce mortality rates and improve the survival and recovery of severely injured patients. With a solid foundation in clinical excellence, academic rigor, and a vision for improving trauma systems, Dr. Choi stands out as a leading contributor in his field.

Professional Profile

Education

Dr. Young Un Choi has pursued a comprehensive medical education that forms the foundation of his clinical and research expertise. He began his medical studies at Inje University College of Medicine from March 2000 to February 2008, where he earned his medical degree. Demonstrating a strong interest in further specialization, he pursued a Master’s degree at the same institution from March 2011 to February 2017, focusing on advanced surgical practices and trauma management. His academic journey continued with a Ph.D. from Yonsei University Wonju College of Medicine, which he completed between March 2019 and February 2022. This doctoral program allowed him to delve deeply into the field of trauma surgery, focusing on the complex interrelationships between surgical techniques, patient outcomes, and trauma care systems. Throughout his academic development, Dr. Choi consistently balanced clinical responsibilities with advanced studies, equipping him with both theoretical knowledge and practical proficiency. His educational progression reflects a deliberate effort to strengthen his expertise in emergency medicine and critical care, positioning him to contribute meaningful advancements in these domains. The combination of medical, master’s, and doctoral degrees underscores his commitment to lifelong learning and clinical excellence, ultimately shaping him into a highly skilled and knowledgeable leader in trauma and critical care research.

Professional Experience

Dr. Young Un Choi has built an impressive career with extensive professional experience across multiple clinical and academic roles. He began his journey in 2008 as an intern doctor at Good Samsun Hospital, followed by residency training in surgery at Inje University Ilsan Paik Hospital from 2009 to 2013. His early focus on pediatric surgery led him to a short-term observer fellowship at Samsung Medical Center in 2013. From 2013 to 2015, he served as a clinical instructor in surgery at Inje University Ilsan Paik Hospital. His international exposure includes working as a medical doctor for the Korea International Cooperation Agency at the Korean-Laos Children’s Hospital between 2015 and 2016, contributing to global medical aid. In 2016, Dr. Choi joined Yonsei University as a Clinical Research Assistant Professor in trauma and intensive care, advancing through academic ranks to his current role as Clinical Associate Professor at Wonju Severance Christian Hospital. His career is marked by consistent growth in trauma surgery and critical care, and he has played a crucial role in clinical education and the development of trauma systems. His professional timeline showcases a dynamic balance between clinical excellence, academic service, and humanitarian medical missions.

Research Interest

Dr. Young Un Choi’s primary research interests focus on trauma surgery, emergency medicine, critical care management, and surgical outcomes in severely injured patients. His work consistently addresses challenges in managing complex trauma cases, particularly blunt abdominal and chest injuries, as well as the evaluation and optimization of diagnostic and surgical interventions. Dr. Choi is especially interested in improving the early identification of critical injuries, developing efficient trauma assessment methods, and refining surgical protocols to reduce mortality and complication rates. He has a strong focus on the utilization of radiographic techniques in trauma diagnosis, the prevention and management of surgical site infections, and strategies for enhancing survival in patients with severe polytrauma. Additionally, his research covers postoperative critical care and the role of advanced therapies such as immunoglobulin administration and antithrombin III in trauma patients. Dr. Choi also explores trauma care efficiency during mass gatherings and pandemics, as reflected in his study of trauma center responses during the COVID-19 outbreak. His body of research contributes to the global effort to improve trauma systems, optimize critical care practices, and develop evidence-based guidelines that can be applied both regionally and internationally.

Research Skills

Dr. Young Un Choi possesses a comprehensive skill set in trauma surgery, emergency procedures, critical care, and clinical research methodologies. He is proficient in advanced trauma life support (ATLS), emergency surgical techniques, preperitoneal pelvic packing, and hemodynamic stabilization strategies for severely injured patients. Dr. Choi is highly skilled in utilizing diagnostic tools such as chest radiography and computed tomography in emergency trauma settings, allowing for rapid and accurate injury assessment. His clinical expertise extends to the management of complex abdominal and thoracic injuries, as well as the application of advanced resuscitation protocols in critical care. In addition to his clinical abilities, Dr. Choi is adept at conducting retrospective and prospective clinical studies, employing data analysis, outcome measurement, and cohort study designs to derive meaningful conclusions from patient cases. His proficiency in multi-disciplinary trauma care and his ability to integrate research into clinical practice are evident throughout his published work. Furthermore, he has strong teaching and mentorship skills, regularly contributing to academic activities, surgical training, and national trauma courses. Dr. Choi’s unique combination of hands-on surgical skills, trauma management expertise, and rigorous clinical research make him a valuable contributor to both academic and hospital settings.

Awards and Honors

Dr. Young Un Choi’s distinguished career is supported by several certifications, memberships, and recognitions in the field of trauma and emergency medicine. He holds board certifications in general surgery, trauma surgery, critical care medicine, and emergency trauma surgery, reflecting his multi-specialty proficiency. Dr. Choi has completed numerous internationally recognized training programs, including Advanced Trauma Life Support (ATLS) from Sunnybrook Health Sciences Centre in Canada and the Definitive Surgical Trauma Care (DSTC) course in Sydney, Australia. He is certified in specialized courses such as Advanced Trauma Operative Management (ATOM) and Korean Advanced Life Support (KALS), among others. Dr. Choi is an active member of several professional societies, including the Korean Surgical Society, the Korean Society of Acute Care Surgery, the Korean Society of Traumatology, and the Korean Society of Critical Care Medicine. His involvement in these organizations signifies his dedication to continuous professional development and knowledge dissemination. In addition to his certifications and society memberships, Dr. Choi has served as an instructor for several national trauma training courses, playing a vital role in the education and training of upcoming trauma surgeons and emergency care providers. His honors and certifications underscore his expertise and leadership in the trauma field.

Conclusion

Dr. Young Un Choi is a dedicated and highly skilled trauma surgeon and clinical researcher whose contributions to emergency and critical care medicine are both extensive and impactful. His academic journey, clinical excellence, and substantial research output position him as a leader in trauma care in South Korea. Through his focused research on trauma mechanisms, surgical interventions, and critical care strategies, Dr. Choi has significantly advanced the understanding and management of severe trauma cases. His consistent participation in national and international trauma societies and his role in surgical education further highlight his influence within the medical community. Although his accomplishments are already remarkable, Dr. Choi has opportunities to expand his global collaborations, increase involvement in multicenter trials, and explore innovative technologies to further elevate his contributions to the field. His ability to balance clinical duties, research, and education is commendable and demonstrates his commitment to improving patient care and trauma system efficiency. Overall, Dr. Choi’s professional journey reflects a rare combination of surgical expertise, academic dedication, and passion for advancing trauma care, making him a deserving candidate for the Best Researcher Award.

Publications Top Notes

  • Differences in Characteristics of Trauma Between General Trauma and Suicidal Trauma–Trauma Mechanism, Injury Site, and Severity: A Single‐Center Study
    Ji Young Hyun, Yae Jun Son, SuHyun Kim, Keum Seok Bae, Jae Sik Chung, Il Hwan Park, Young Un Choi, Roberto Cirocchi
    2025

  • Mortality Trends in Chest-Abdominal Trauma Patients Before and After the Establishment of Trauma Centers in South Korea
    Dae Ryong Kang, Hye Sim Kim, Ji Young Jang, Ou-Hyen Kim, Kiyoung Kim, Un Young Choi, Jiwool Ko, Keum Seok Bae, Hongjin Shim
    2024

  • Occult Pneumothorax in Patients with Blunt Chest Trauma: Key Findings on Supine Chest Radiography
    Il Hwan Park, Chang Wan Kim, Young Un Choi, Tae Wook Kang, Jihye Lim, Chun Sung Byun
    2023

  • Association of Chest Anteroposterior Radiography with Computed Tomography in Patients with Blunt Chest Trauma
    Young Un Choi, Chang Whan Kim, JiHye Lim, Il Hwan Park, Chun Sung Byun, Roberto Cirocchi
    2023

  • Effect of Antithrombin III Administration on the Prognosis of Severe Trauma Patients with Disseminated Intravascular Coagulation
    Jae Sik Chung, Myoung Jun Kim, Young Un Choi, Jun Gi Kim, Keum Seok Bae
    2023

  • Adjuvant Intravenous Immunoglobulin Administration on Postoperative Critically Ill Patients with Secondary Peritonitis: A Retrospective Study
    Young Un Choi, Jun Gi Kim, Ji Young Jang, Tae Hwa Go, Kwangmin Kim, Keum Seok Bae, Hongjin Shim
    2023

  • Outcomes Improvement Despite Continuous Visits of Severely Injured Patients During the COVID-19 Outbreak: Experience at a Regional Trauma Centre in South Korea
    Young Un Choi
    2022

  • Determination of Risk Factors for Predicting Bladder-Urethra Injury in Cases of Pelvic Bone Fracture: A Retrospective Single Center Study
    Ji Wool Ko, Myoung Jun Kim, Young Un Choi, Hongjin Shim, Hoejeong Chung, Ji Young Jang, Keum Seok Bae, Kwangmin Kim
    2022

  • A Study on Trauma Mechanisms and Injury Sites in Patients with Blunt Abdominal Trauma
    YoungUn Choi, SuHyun Kim, JiWool Ko, MyoungJun Kim, Hongjin Shim, JaeHun Han, JiHye Lim, Kwangmin Kim, Roberto Cirocchi
    2022

  • Determination of Risk Factors Associated with Surgical Site Infection in Patients Undergoing Preperitoneal Pelvic Packing for Unstable Pelvic Fracture
    Kang Min Kim, Myoung Jun Kim, Jae Sik Chung, Ji Wool Ko, Young Un Choi, Hongjin Shim, Ji Young Jang, Keum Seok Bae, Kwangmin Kim
    2022